EMA Poised To Decide On Fate Of Lilly’s Kisunla And PharmaMar’s Aplidin In EU

 
• By Vibha Sharma
  
People standing out from the crowd. Human resource, Talent management, Recruitment employee, Successful business team leader. red figure, leadership concept. Leader standing out from the crown
EMA’s rejection of Kisunla was out of step with the decisions of other regulatory agencies (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from EU CHMP

More from Product Reviews